BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31446084)

  • 21. The Current Understanding of Autophagy in Nanomaterial Toxicity and Its Implementation in Safety Assessment-Related Alternative Testing Strategies.
    Chen RJ; Chen YY; Liao MY; Lee YH; Chen ZY; Yan SJ; Yeh YL; Yang LX; Lee YL; Wu YH; Wang YJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental toxicity of glycine-coated silica nanoparticles in embryonic zebrafish.
    Dumitrescu E; Karunaratne DP; Prochaska MK; Liu X; Wallace KN; Andreescu S
    Environ Pollut; 2017 Oct; 229():439-447. PubMed ID: 28623802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The question of toxicity of nanomaterials and nanoparticles.
    Allen C
    J Control Release; 2019 Jun; 304():288. PubMed ID: 31185234
    [No Abstract]   [Full Text] [Related]  

  • 24. Application of embryonic and adult zebrafish for nanotoxicity assessment.
    Wang J; Zhu X; Chen Y; Chang Y
    Methods Mol Biol; 2012; 926():317-29. PubMed ID: 22975972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of potential environmental toxicity of polymeric nanomaterials and surfactants.
    Hering I; Eilebrecht E; Parnham MJ; Günday-Türeli N; Türeli AE; Weiler M; Schäfers C; Fenske M; Wacker MG
    Environ Toxicol Pharmacol; 2020 May; 76():103353. PubMed ID: 32086102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light-responsive nanomedicine for biophotonic imaging and targeted therapy.
    Son J; Yi G; Yoo J; Park C; Koo H; Choi HS
    Adv Drug Deliv Rev; 2019 Jan; 138():133-147. PubMed ID: 30321619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical responses upon the interaction of nanomaterials with cellular interfaces.
    Wu YL; Putcha N; Ng KW; Leong DT; Lim CT; Loo SC; Chen X
    Acc Chem Res; 2013 Mar; 46(3):782-91. PubMed ID: 23194178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomaterials in food and agriculture: An overview on their safety concerns and regulatory issues.
    Jain A; Ranjan S; Dasgupta N; Ramalingam C
    Crit Rev Food Sci Nutr; 2018 Jan; 58(2):297-317. PubMed ID: 27052385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and toxicity of nanomaterials for ocular drug delivery applications.
    Mehra NK; Cai D; Kuo L; Hein T; Palakurthi S
    Nanotoxicology; 2016 Sep; 10(7):836-60. PubMed ID: 27027670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay.
    Rizzo LY; Golombek SK; Mertens ME; Pan Y; Laaf D; Broda J; Jayapaul J; Möckel D; Subr V; Hennink WE; Storm G; Simon U; Jahnen-Dechent W; Kiessling F; Lammers T
    J Mater Chem B; 2013 Jun; 1():. PubMed ID: 24179674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotoxicity Assessment Using Embryonic Zebrafish.
    Dumitrescu E; Wallace K; Andreescu S
    Methods Mol Biol; 2019; 1894():331-343. PubMed ID: 30547471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety assessment of nanomaterials: implications for nanomedicine.
    Nyström AM; Fadeel B
    J Control Release; 2012 Jul; 161(2):403-8. PubMed ID: 22306428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth-Based Bacterial Viability Assay for Interference-Free and High-Throughput Toxicity Screening of Nanomaterials.
    Qiu TA; Nguyen TH; Hudson-Smith NV; Clement PL; Forester DC; Frew H; Hang MN; Murphy CJ; Hamers RJ; Feng ZV; Haynes CL
    Anal Chem; 2017 Feb; 89(3):2057-2064. PubMed ID: 28208291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated phenotype recognition for zebrafish embryo based in vivo high throughput toxicity screening of engineered nano-materials.
    Liu R; Lin S; Rallo R; Zhao Y; Damoiseaux R; Xia T; Lin S; Nel A; Cohen Y
    PLoS One; 2012; 7(4):e35014. PubMed ID: 22506062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential applications and human biosafety of nanomaterials used in nanomedicine.
    Su H; Wang Y; Gu Y; Bowman L; Zhao J; Ding M
    J Appl Toxicol; 2018 Jan; 38(1):3-24. PubMed ID: 28589558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.